213 related articles for article (PubMed ID: 25732488)
1. New analysis reexamines the value of cancer care in the United States compared to Western Europe.
Soneji S; Yang J
Health Aff (Millwood); 2015 Mar; 34(3):390-7. PubMed ID: 25732488
[TBL] [Abstract][Full Text] [Related]
2. How should we value lives lost to cancer?
Ramsey SD
J Natl Cancer Inst; 2008 Dec; 100(24):1742-3. PubMed ID: 19066279
[No Abstract] [Full Text] [Related]
3. Estimating the cost of cancer care in the United States: a work very much in progress.
Lipscomb J
J Natl Cancer Inst; 2008 May; 100(9):607-10. PubMed ID: 18445816
[No Abstract] [Full Text] [Related]
4. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
Hristova L; Hakama M
Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
[TBL] [Abstract][Full Text] [Related]
5. Cost of care for elderly cancer patients in the United States.
Yabroff KR; Lamont EB; Mariotto A; Warren JL; Topor M; Meekins A; Brown ML
J Natl Cancer Inst; 2008 May; 100(9):630-41. PubMed ID: 18445825
[TBL] [Abstract][Full Text] [Related]
6. Variations in cancer survival and patterns of care across Europe: roles of wealth and health-care organization.
Gatta G; Trama A; Capocaccia R
J Natl Cancer Inst Monogr; 2013; 2013(46):79-87. PubMed ID: 23962511
[TBL] [Abstract][Full Text] [Related]
7. Estimates and projections of value of life lost from cancer deaths in the United States.
Yabroff KR; Bradley CJ; Mariotto AB; Brown ML; Feuer EJ
J Natl Cancer Inst; 2008 Dec; 100(24):1755-62. PubMed ID: 19066267
[TBL] [Abstract][Full Text] [Related]
8. Area-level variations in cancer care and outcomes.
Keating NL; Landrum MB; Lamont EB; Bozeman SR; McNeil BJ
Med Care; 2012 May; 50(5):366-73. PubMed ID: 22437623
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of trends in the cost of initial cancer treatment.
Warren JL; Yabroff KR; Meekins A; Topor M; Lamont EB; Brown ML
J Natl Cancer Inst; 2008 Jun; 100(12):888-97. PubMed ID: 18544740
[TBL] [Abstract][Full Text] [Related]
10. Costs of cancer care for use in economic evaluation: a UK analysis of patient-level routine health system data.
Hall PS; Hamilton P; Hulme CT; Meads DM; Jones H; Newsham A; Marti J; Smith AF; Mason H; Velikova G; Ashley L; Wright P
Br J Cancer; 2015 Mar; 112(5):948-56. PubMed ID: 25602964
[TBL] [Abstract][Full Text] [Related]
11. Estimating Costs of Care Attributable to Cancer: Does the Choice of Comparison Group Matter?
Chen AB; Li L; Cronin AM; Brooks GA; Kavanagh BD; Schrag D
Health Serv Res; 2018 Aug; 53 Suppl 1(Suppl Suppl 1):3227-3244. PubMed ID: 28858372
[TBL] [Abstract][Full Text] [Related]
12. Estimating the cost of caring for people with cancer at the end of life: A modelling study.
Round J; Jones L; Morris S
Palliat Med; 2015 Dec; 29(10):899-907. PubMed ID: 26199134
[TBL] [Abstract][Full Text] [Related]
13. Is spending more always wasteful? The appropriateness of care and outcomes among colorectal cancer patients.
Landrum MB; Meara ER; Chandra A; Guadagnoli E; Keating NL
Health Aff (Millwood); 2008; 27(1):159-68. PubMed ID: 18180491
[TBL] [Abstract][Full Text] [Related]
14. Expected years of life lost for six potentially preventable cancers in the United States.
Liu PH; Wang JD; Keating NL
Prev Med; 2013 May; 56(5):309-13. PubMed ID: 23428566
[TBL] [Abstract][Full Text] [Related]
15. Cancer outcomes in low-income elders: is there an advantage to being on Medicaid?
Koroukian SM; Bakaki PM; Owusu C; Earle CC; Cooper GS
Medicare Medicaid Res Rev; 2012; 2(2):. PubMed ID: 24800139
[TBL] [Abstract][Full Text] [Related]
16. Cancer mortality surveillance--United States, 1990-2000.
Stewart SL; King JB; Thompson TD; Friedman C; Wingo PA
MMWR Surveill Summ; 2004 Jun; 53(3):1-108. PubMed ID: 15179359
[TBL] [Abstract][Full Text] [Related]
17. Cancer survival in Germany and the United States at the beginning of the 21st century: an up-to-date comparison by period analysis.
Gondos A; Arndt V; Holleczek B; Stegmaier C; Ziegler H; Brenner H
Int J Cancer; 2007 Jul; 121(2):395-400. PubMed ID: 17372898
[TBL] [Abstract][Full Text] [Related]
18. Prospective cost-effectiveness analysis of cetuximab in metastatic colorectal cancer: evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 trial.
Mittmann N; Au HJ; Tu D; O'Callaghan CJ; Isogai PK; Karapetis CS; Zalcberg JR; Evans WK; Moore MJ; Siddiqui J; Findlay B; Colwell B; Simes J; Gibbs P; Links M; Tebbutt NC; Jonker DJ; ;
J Natl Cancer Inst; 2009 Sep; 101(17):1182-92. PubMed ID: 19666851
[TBL] [Abstract][Full Text] [Related]
19. Are we finally winning the war on cancer?
Cutler DM
J Econ Perspect; 2008; 22(4):3-26. PubMed ID: 19768842
[No Abstract] [Full Text] [Related]
20. The economic burden of cancer in the UK: a study of survivors treated with curative intent.
Marti J; Hall PS; Hamilton P; Hulme CT; Jones H; Velikova G; Ashley L; Wright P
Psychooncology; 2016 Jan; 25(1):77-83. PubMed ID: 26087260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
